<--- Back to Details
First PageDocument Content
Nanocell / Cancer treatments / Angiogenesis / Chemotherapy / Liposome / Vascular endothelial growth factor / Combretastatin / Doxorubicin / Radiation therapy / Medicine / Angiology / Dosage forms
Date: 2013-02-01 02:06:14
Nanocell
Cancer treatments
Angiogenesis
Chemotherapy
Liposome
Vascular endothelial growth factor
Combretastatin
Doxorubicin
Radiation therapy
Medicine
Angiology
Dosage forms

Add to Reading List

Source URL: www.medicine-science.net23.net

Download Document from Source Website

File Size: 559,74 KB

Share Document on Facebook

Similar Documents

Tyrosine kinase / Combretastatin / Angiogenesis inhibitor / Tyrosine-kinase inhibitor / AEE788 / Angiogenesis / Chemistry / Angiology / Protein kinase inhibitors / Combretastatin A-4 phosphate

Konstantina Grosios PhD, MPH Biomedical and Health Research Centre (BHRC) & Cancer Research UK Cancer Centre (CR-UK CC) Research Manager University of Leeds, Leeds, UK

DocID: 11Oho - View Document

Biomarker / Combretastatin / Vascular endothelial growth factor / Radiation therapy / Cetuximab / Immunohistochemistry / Medicine / Angiology / Angiogenesis

Exploration of the clinical interaction between vascular targeting agents and radiotherapy

DocID: NU66 - View Document

Cancer research / Angiogenesis / Combretastatin

Non-invasive (MR, PET and CT) Pharmacokinetic and Pharmacodynamic Evaluation of Poly-(ADP-Ribose)-Polymerase (PARP) inhibitors

DocID: nNR6 - View Document

Nanocell / Cancer treatments / Angiogenesis / Chemotherapy / Liposome / Vascular endothelial growth factor / Combretastatin / Doxorubicin / Radiation therapy / Medicine / Angiology / Dosage forms

PDF Document

DocID: 7TkV - View Document

Experimental cancer treatment / Cancer research / Metastasis / Stromal cell-derived factor-1 / Stilbenoids / Medicine / Combretastatin

British Journal of Cancer[removed]), 1318–1327 © 1999 Cancer Research Campaign Article no. bjoc[removed]

DocID: 20ge - View Document